AAAAAA

   
Results: 1-10 |
Results: 10
Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and ss(2)-microglobulin in patients with congestive heart failure
Authors: Vesely, DL Perez-Lamboy, GI Schocken, DD
Citation: Dl. Vesely et al., Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and ss(2)-microglobulin in patients with congestive heart failure, J CARD FAIL, 7(1), 2001, pp. 55-63
Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol
Authors: Vesely, DL San Miguel, GI Hassan, I Schocken, DD
Citation: Dl. Vesely et al., Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol, J CLIN END, 86(9), 2001, pp. 4244-4249
Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and free T-4 and free T-3 with reciprocal increase in TSH
Authors: Vesely, DL San Miguel, GI Hassan, I Gower, WR Schocken, DD
Citation: Dl. Vesely et al., Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and free T-4 and free T-3 with reciprocal increase in TSH, J CLIN END, 86(11), 2001, pp. 5438-5442
Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure
Authors: Nasser, A Dietz, JR Siddique, M Patel, H Khan, N Antwi, EK San Miguel, GI McCormick, MT Schocken, DD Vesely, DL
Citation: A. Nasser et al., Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure, AM J CARD, 88(1), 2001, pp. 23-29
Epidemiology and risk factors for heart failure in the elderly
Authors: Schocken, DD
Citation: Dd. Schocken, Epidemiology and risk factors for heart failure in the elderly, CLIN GERIAT, 16(3), 2000, pp. 407
Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta(2)-microglobulin
Authors: Vesely, DL Perez-Lamboy, GI Schocken, DD
Citation: Dl. Vesely et al., Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta(2)-microglobulin, METABOLISM, 49(12), 2000, pp. 1592-1597
Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E-2
Authors: Vesely, DL Perez-Lamboy, GI Schocken, DD
Citation: Dl. Vesely et al., Vessel dilator, long acting natriuretic peptide, and kaliuretic peptide increase circulating prostaglandin E-2, LIFE SCI, 66(10), 2000, pp. 905-913
Diabetic cardiomyopathy and carnitine deficiency
Authors: Malone, JI Schocken, DD Morrison, AD Gilbert-Barness, E
Citation: Ji. Malone et al., Diabetic cardiomyopathy and carnitine deficiency, J DIABET C, 13(2), 1999, pp. 86-90
Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators (vol 36, pg 246, 1997)
Authors: Daggubati, S Parks, JR Overton, RM Cintron, G Schocken, DD Vesely, DL
Citation: S. Daggubati et al., Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators (vol 36, pg 246, 1997), CARDIO RES, 44(2), 1999, pp. 452-453
Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure
Authors: Vesely, DL Dietz, JR Parks, JR Antwi, EA Overton, RM McCormick, MT Cintron, G Schocken, DD
Citation: Dl. Vesely et al., Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure, AM HEART J, 138(4), 1999, pp. 625-632
Risultati: 1-10 |